Derick Sonjong
Psychiatric/Mental Health · Owings Mills, MDNPI 1851047690
Payments from drug & device makers
Across 173 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$646
- Neurocrine Biosciences, Inc.$507
- Teva Pharmaceuticals USA, Inc.$485
- Lundbeck LLC$473
- Alkermes, Inc.$369
- Otsuka America Pharmaceutical, Inc.$313
- plus $862 from 9 others
What the payments were for
- Food & beverage$3,52596%
- Education$1324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $646 |
| Neurocrine Biosciences, Inc. | 20 | $507 |
| Teva Pharmaceuticals USA, Inc. | 21 | $485 |
| Lundbeck LLC | 30 | $473 |
| Alkermes, Inc. | 20 | $369 |
| Otsuka America Pharmaceutical, Inc. | 11 | $313 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $311 |
| Vanda Pharmaceuticals Inc. | 5 | $107 |
| Johnson & Johnson | 4 | $99 |
| Corium, LLC | 4 | $98 |
| Indivior Inc. | 4 | $98 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| Almatica Pharma LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,656 in reported general payments places this provider in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 57 | $79,573 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $5,269 |
| Paliperidone ErPaliperidone | 11 | $3,481 |
| Lurasidone Hcl | 13 | $2,983 |
| Hydroxyzine Hcl | 76 | $1,713 |
| Ziprasidone Hcl | 23 | $1,375 |
| Clonazepam | 86 | $1,076 |
| Quetiapine Fumarate | 58 | $901 |
| Trazodone Hcl | 87 | $703 |
| Olanzapine | 19 | $562 |
| Guanfacine Hcl ErGuanfacine Hcl | 12 | $499 |
| Bupropion XlBupropion Hcl | 26 | $435 |
| Benztropine Mesylate | 19 | $291 |
| Clonidine Hcl | 13 | $258 |
| Buspirone Hcl | 31 | $246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $646 | $79,57357 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.
Other psychiatric/mental health in Owings Mills
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
- Anyinke AtabongRockville$15K
- Zenatsehay GebretsadikColumbia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.